Neutrophils are mobilized to the vascular wall during vessel inflammation. Published data are conflicting on phagocytic nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activation during the hypertensive state, and the capacity of angiotensin II (Ang II) to modulate the intracellular redox status has not been analyzed in neutrophils. We here describe that Ang II highly stimulates endogenous and extracellular O 2 ؊ production in these cells, consistent with the translocation to the cell membrane of the cytosolic components of NADPH oxidase, p47 phox , and p67 phox . The Ang II-dependent O 2 ؊ production was suppressed by specific inhibitors of AT1 receptors, of the p38MAPK and ERK1/2 pathways, and of flavin oxidases. Furthermore, Ang II induced a robust phosphorylation of p38MAPK, ERK1/2, and JNK1/2 (particularly JNK2), which was hindered by inhibitors of NADPH oxidase, tyrosine kinases, and ROS scavengers. Ang II increased cytosolic Ca 2؉ levels-released mainly from calcium stores-enhanced the syn- IntroductionAngiotensin II (Ang II), the main peptide hormone of the reninangiotensin system, induces leukocyte recruitment to the vessel wall, which constitutes a hallmark of the early stages of atherosclerosis and several hypertensive diseases. 1 In addition, it plays a regulatory role on blood pressure and circulation volume and on the proliferation of vascular smooth muscle cells. 2 Ang II acts through high-affinity cell surface receptors (AT1), which are linked to pathways classically associated with G-protein-coupled and tyrosine-kinase-mediated responses. 3 Although most studies on Ang II have been carried out in smooth muscle and endothelial cells, experimental evidence has been obtained on its effects on circulating cells. AT1 receptors for Ang II have been found recently in circulating neutrophils 4 and human peripheral monocytes, 5 and Ang II-induced cell activation in the latter has been reported. 6 In this context, the migration of leukocytes from blood to sites of inflammation and their adhesion to endothelial cells are primary events taking place during the acute inflammatory response and the pathogenesis of vascular diseases. 7 Because chronic inflammation of vessel walls is a hallmark of atherosclerosis, 8 and reactive oxygen species (ROS) such as superoxide anion (O 2 Ϫ ) and H 2 O 2 constitute the main intermediary molecules responsible for inflammation, 9 a link between atherosclerosis and ROS production has been postulated. 10 Nicotinamideadenine dinucleotide phosphate (NADPH) oxidase of phagocytes catalyzes the reduction of oxygen to O 2 Ϫ . In resting cells this enzyme is inactive, and its components are distributed between the cytosol and the membrane of secretory vesicles. When phagocytic cells are activated, the enzyme's cytosolic components associate to membrane-bound components and assemble into catalytically active NADPH oxidase. 11 It has been reported that Ang II-induced hypertrophy of vascular smooth muscle cells is mediated by both O 2 Ϫ and H 2 O 2 . 12 In addition, ROS ha...

15-Deoxy-⌬12,14 -prostaglandin J 2 (15dPGJ 2 ) has been proposed recently as a potent anti-inflammatory agent. However, the mechanisms by which 15dPGJ 2 mediates its therapeutic effects in vivo are unclear. We demonstrate that 15dPGJ 2 at micromolar (2.5-10 M) concentrations induces the expression of heme oxygenase-1 (HO-1), an anti-inflammatory enzyme, at both mRNA and protein levels in human lymphocytes. In contrast, troglitazone and ciglitazone, two thiazolidinediones that mimic several effects of 15dPGJ 2 through their binding to the peroxisome proliferator-activated receptor (PPAR)-␥, did not affect HO-1 expression, and the positive effect of 15dPGJ 2 on this process was mimicked instead by other cyclopentenone prostaglandins (PG), such as PGD 2 (the precursor of 15dPGJ 2 ) and PGA 1 and PGA 2 which do not interact with PPAR-␥. Also, 15dPGJ 2 enhanced the intracellular production of reactive oxygen species (ROS) and increased xanthine oxidase activity in vitro. Inhibition of intracellular ROS production by N-acetylcysteine, TEMPO, Me 2 SO, 1,10-phenanthroline, or allopurinol resulted in a decreased 15dPGJ 2 -dependent HO-1 expression in the cells. Furthermore, buthionine sulfoximine, an inhibitor of reduced glutathione synthesis, or Fe 2؉ /Cu 2؉ ions enhanced the positive effect of 15dPGJ 2 on HO-1 expression. On the other hand, the inhibition of phosphatidylinositol 3-kinase or p38 mitogen-activated protein kinase, or the blockade of transcription factor NF-B activation, hindered 15dPGJ 2 -elicited HO-1 expression. Collectively, the present data suggest that 15dPGJ 2 anti-inflammatory actions at pharmacological concentrations involve the induction of HO-1 gene expression through mechanisms independent of PPAR-␥ activation and dependent on ROS produced via the xanthine/xanthine oxidase system and/or through Fenton reactions. Both phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways also appear implicated in modulation of HO-1 expression by 15dPGJ 2 .